VALLEY FORGE INVESTMENT CONSULTANTS INC ADV
Position in NGEN — Nervgen Pharma Corp.
CIK 920655
AUDUBON, PA
Position in NGEN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$20,600
-$272,321 QoQ
Shares Held
10,000
-87.1% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#54
of 62 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VALLEY FORGE INVESTMENT CONSULTANTS INC ADV holds $687,232 across 2 Biotechnology names. NGEN ranks #2 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SPRY |
ARS Pharmaceuticals, Inc.
|
83,225 | $666,632 | |
| 2 | NGEN |
Nervgen Pharma Corp.
This page
|
10,000 | $20,600 |
All Filings in NGEN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,600 | 10,000 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $292,921 | 77,698 | Shares | Sole | 2026-04-21 | |
| No filing history on record for this holder in this stock. | ||||||